PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MDGL vs. KBH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MDGL and KBH is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

MDGL vs. KBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Madrigal Pharmaceuticals, Inc. (MDGL) and KB Home (KBH). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
2.29%
-15.18%
MDGL
KBH

Key characteristics

Sharpe Ratio

MDGL:

0.34

KBH:

0.42

Sortino Ratio

MDGL:

1.02

KBH:

0.85

Omega Ratio

MDGL:

1.12

KBH:

1.10

Calmar Ratio

MDGL:

0.38

KBH:

0.50

Martin Ratio

MDGL:

1.41

KBH:

1.42

Ulcer Index

MDGL:

15.82%

KBH:

10.32%

Daily Std Dev

MDGL:

65.46%

KBH:

35.24%

Max Drawdown

MDGL:

-98.40%

KBH:

-92.78%

Current Drawdown

MDGL:

-28.35%

KBH:

-24.01%

Fundamentals

Market Cap

MDGL:

$6.40B

KBH:

$4.93B

EPS

MDGL:

-$26.96

KBH:

$8.40

PEG Ratio

MDGL:

0.00

KBH:

0.63

Total Revenue (TTM)

MDGL:

$76.81M

KBH:

$6.93B

Gross Profit (TTM)

MDGL:

$73.59M

KBH:

$3.05B

EBITDA (TTM)

MDGL:

-$394.57M

KBH:

$828.65M

Returns By Period

In the year-to-date period, MDGL achieves a -4.84% return, which is significantly lower than KBH's 3.30% return. Over the past 10 years, MDGL has underperformed KBH with an annualized return of 13.05%, while KBH has yielded a comparatively higher 20.05% annualized return.


MDGL

YTD

-4.84%

1M

-4.80%

6M

2.29%

1Y

29.65%

5Y*

28.86%

10Y*

13.05%

KBH

YTD

3.30%

1M

3.08%

6M

-15.18%

1Y

12.19%

5Y*

13.87%

10Y*

20.05%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MDGL vs. KBH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MDGL
The Risk-Adjusted Performance Rank of MDGL is 6060
Overall Rank
The Sharpe Ratio Rank of MDGL is 5959
Sharpe Ratio Rank
The Sortino Ratio Rank of MDGL is 6060
Sortino Ratio Rank
The Omega Ratio Rank of MDGL is 5757
Omega Ratio Rank
The Calmar Ratio Rank of MDGL is 6363
Calmar Ratio Rank
The Martin Ratio Rank of MDGL is 6161
Martin Ratio Rank

KBH
The Risk-Adjusted Performance Rank of KBH is 5959
Overall Rank
The Sharpe Ratio Rank of KBH is 6161
Sharpe Ratio Rank
The Sortino Ratio Rank of KBH is 5656
Sortino Ratio Rank
The Omega Ratio Rank of KBH is 5252
Omega Ratio Rank
The Calmar Ratio Rank of KBH is 6868
Calmar Ratio Rank
The Martin Ratio Rank of KBH is 6161
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MDGL vs. KBH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Madrigal Pharmaceuticals, Inc. (MDGL) and KB Home (KBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MDGL, currently valued at 0.34, compared to the broader market-2.000.002.004.000.340.42
The chart of Sortino ratio for MDGL, currently valued at 1.02, compared to the broader market-4.00-2.000.002.004.006.001.020.85
The chart of Omega ratio for MDGL, currently valued at 1.12, compared to the broader market0.501.001.502.001.121.10
The chart of Calmar ratio for MDGL, currently valued at 0.38, compared to the broader market0.002.004.006.000.380.50
The chart of Martin ratio for MDGL, currently valued at 1.41, compared to the broader market-10.000.0010.0020.0030.001.411.42
MDGL
KBH

The current MDGL Sharpe Ratio is 0.34, which is comparable to the KBH Sharpe Ratio of 0.42. The chart below compares the historical Sharpe Ratios of MDGL and KBH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50AugustSeptemberOctoberNovemberDecember2025
0.34
0.42
MDGL
KBH

Dividends

MDGL vs. KBH - Dividend Comparison

MDGL has not paid dividends to shareholders, while KBH's dividend yield for the trailing twelve months is around 1.40%.


TTM20242023202220212020201920182017201620152014
MDGL
Madrigal Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
KBH
KB Home
1.40%1.45%1.12%1.88%1.34%1.25%0.67%0.52%0.31%0.63%0.81%0.60%

Drawdowns

MDGL vs. KBH - Drawdown Comparison

The maximum MDGL drawdown since its inception was -98.40%, which is greater than KBH's maximum drawdown of -92.78%. Use the drawdown chart below to compare losses from any high point for MDGL and KBH. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-28.35%
-24.01%
MDGL
KBH

Volatility

MDGL vs. KBH - Volatility Comparison

Madrigal Pharmaceuticals, Inc. (MDGL) has a higher volatility of 19.10% compared to KB Home (KBH) at 8.87%. This indicates that MDGL's price experiences larger fluctuations and is considered to be riskier than KBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%AugustSeptemberOctoberNovemberDecember2025
19.10%
8.87%
MDGL
KBH

Financials

MDGL vs. KBH - Financials Comparison

This section allows you to compare key financial metrics between Madrigal Pharmaceuticals, Inc. and KB Home. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab